AI assistant
Sending…
MetaVia Inc. — Director's Dealing 2024
Jun 25, 2024
34919_dirs_2024-06-25_d7f29bf7-84c2-4a6e-a431-b815f21e0672.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2024-06-23
Reporting Person: DONG-A ST CO., LTD (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-23 | Common Stock | P | 2544530 | $3.13 | Acquired | 5348229 | Direct |
More from MetaVia Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Apr 3